|
It was reported the physician used the gore-tex® suture.Reportedly, the first suture start fraying, then a second suture was used and it start fraying as well.It was reported the 3rd suture used worked fine.Reportedly, the procedure being performed was augmentation-mastopexy.It was reported, the surgeon thought because the fray was at the end of the suture the proximal portion would be ok.It subsequently frayed in the patients body.Reportedly, a dehiscence along the surgical incision occurred, but was repaired with additional sutures.
|
|
H6 - code 4111: additional information regarding the event were requested from the physician.The provided additional information is captured in the event description.The gore-tex® suture instructions for use (ifu) state: possible adverse reactions associated with the use of any suture include, but are not limited to, tissue dehiscence, infection, localized inflammatory reaction, and transitory local irritation.Broken needles or damaged thread may result in extended or additional surgery or retained foreign bodies.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|